サマリー

ブレインヘルスサプリメントの世界市場 2021-2025
Technavioは脳の健康サプリメント市場を監視しており、2021年から2025年の間に17億6000万ドルの成長が見込まれ、予測期間中に6.93％のCAGRで進行していることを確認しています。当レポートでは、脳の健康サプリメント市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、都市人口の増加、販売店の増加、高齢者人口の増加によって牽引されています。また、都市人口の増加も市場の成長を後押しすると予想されます。
脳の健康サプリメント市場の分析には、流通チャネルセグメントと地理的展望が含まれます。
Technavioの脳健康サプリメント市場は、以下のようにセグメント化されています。
流通チャネル別
- 小売
- オンライン
地域別状況
- 北米
- ヨーロッパ
- アジア
- 列
本調査では、今後数年間における脳の健康サプリメント市場の成長を促進する主要な理由の1つとして、オンライン小売における需要の増加を挙げています。また、ソーシャルメディアマーケティングによる認知度の向上や、消費者の金銭的な成長も、市場の大きな需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。脳の健康サプリメント市場に関する弊社のレポートは、以下の分野を対象としています。
- 脳の健康サプリメント市場のサイジング
- 脳の健康サプリメント市場予測
- 脳の健康サプリメント市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、Amway Corp、Archer Daniels Midland Co.、Arkopharma Laboratories、BASF SE、Bayer AG、Glanbia Plc、GNC Holdings Inc、Hi-Tech Pharmaceuticals Inc、Koninklijke DSM NVなどの脳の健康サプリメント市場の主要ベンダーについて詳細分析を掲載しています。また、脳の健康サプリメント市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/brain-health-supplements-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1. Executive Summary
• 2. Market Landscape
o 2.1 Market ecosystem
o Exhibit 01: Parent market
o 2.2: Market Characteristics
o Exhibit 02: Market Characteristics
o 2.2 Value chain analysis
o Exhibit 03: Value chain analysis for pharmaceuticals
o 2.2.1 Research and development (R&D) and drug discovery
o 2.2.2 Integration and product development
o 2.2.3 Manufacturing
o 2.2.4 Outbound logistics
o 2.2.5 Marketing and sales
o 2.2.6 Support services
o 2.2.7 Innovation
• 3. Market Sizing
o 3.1 Market definition
o Exhibit 04: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 05: Market segments
o 3.3 Market size 2020
o 3.4 Market outlook: Forecast for 2020 - 2025
o Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
o Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
• 4. Five Forces Analysis
o 4.1 Five Forces Summary
o Exhibit 08: Five forces analysis 2020 & 2025
o 4.2 Bargaining power of buyers
o Exhibit 09: Bargaining power of buyers
o 4.3 Bargaining power of suppliers
o Exhibit 10: Bargaining power of suppliers
o 4.4 Threat of new entrants
o Exhibit 11: Threat of new entrants
o 4.5 Threat of substitutes
o Exhibit 12: Threat of substitutes
o 4.6 Threat of rivalry
o Exhibit 13: Threat of rivalry
o 4.7 Market condition
o Exhibit 14: Market condition - Five forces 2020
• 5. Market Segmentation by Distribution channel
o 5.1 Market segments
o The segments covered in this chapter are:
o o Retail
o o Online
o Exhibit 15: Distribution channel - Market share 2020-2025 (%)
o 5.2 Comparison by Distribution channel
o Exhibit 16: Comparison by Distribution channel
o 5.3 Retail - Market size and forecast 2020-2025
o Exhibit 17: Retail - Market size and forecast 2020-2025 ($ million)
o Exhibit 18: Retail - Year-over-year growth 2020-2025 (%)
o 5.4 Online - Market size and forecast 2020-2025
o Exhibit 19: Online - Market size and forecast 2020-2025 ($ million)
o Exhibit 20: Online - Year-over-year growth 2020-2025 (%)
o 5.5 Market opportunity by Distribution channel
o Exhibit 21: Market opportunity by Distribution channel
• 6. Customer landscape
o 6.1 Overview
o Exhibit 22: Customer landscape
• 7. Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 23: Market share By Geographical Landscape 2020-2025 (%)
o 7.2 Geographic comparison
o Exhibit 24: Geographic comparison
o 7.3 North America - Market size and forecast 2020-2025
o Exhibit 25: North America - Market size and forecast 2020-2025 ($ million)
o Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
o 7.4 Europe - Market size and forecast 2020-2025
o Exhibit 27: Europe - Market size and forecast 2020-2025 ($ million)
o Exhibit 28: Europe - Year-over-year growth 2020-2025 (%)
o 7.5 Asia - Market size and forecast 2020-2025
o Exhibit 29: Asia - Market size and forecast 2020-2025 ($ million)
o Exhibit 30: Asia - Year-over-year growth 2020-2025 (%)
o 7.6 ROW - Market size and forecast 2020-2025
o Exhibit 31: ROW - Market size and forecast 2020-2025 ($ million)
o Exhibit 32: ROW - Year-over-year growth 2020-2025 (%)
o 7.7 Key leading countries
o Exhibit 33: Key leading countries
o 7.8 Market opportunity By Geographical Landscape
o Exhibit 34: Market opportunity By Geographical Landscape ($ million)
• 8. Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.1.1 Growing urban population
o Exhibit 35: Urban population (% of the population), 2019
o 8.1.2 Increase in sales outlets
o 8.1.3 Increase in older adult population
o Exhibit 36: Older population aged 65 years and above (% of the total population), 2019
o 8.2 Market challenges
o 8.2.1 Low penetration in developing regions
o 8.2.2 Stringent government regulations
o 8.2.3 Ignorance about health benefits of brain health supplements
o Exhibit 37: Impact of drivers and challenges
o 8.3 Market trends
o 8.3.1 Growing demand in online retail
o 8.3.2 Increasing awareness through social media marketing
o 8.3.3 Monetary growth among consumers
• 9. Vendor Landscape
o 10.1 Competitive scenario
o 10.2 Vendor landscape
o Exhibit 38: Vendor Landscape
o 10.3 Landscape disruption
o Exhibit 39: Landscape disruption
o 10.4 Industry risks
o Exhibit 40: Industry risks
• 11. Vendor Analysis
o 11.1 Vendors covered
o Exhibit 41: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 42: Market positioning of vendors
o 10.3 Abbott Laboratories
o Exhibit 43: Abbott Laboratories - Overview
o Exhibit 44: Abbott Laboratories - Business segments
o Exhibit 45: Abbott Laboratories - Key news
o Exhibit 46: Abbott Laboratories - Key offerings
o Exhibit 47: Abbott Laboratories - Segment focus
o 10.4 Amway Corp.
o Exhibit 48: Amway Corp. - Overview
o Exhibit 49: Amway Corp. - Product and service
o Exhibit 50: Amway Corp. – Key news
o Exhibit 51: Amway Corp. - Key offerings
o 10.5 Archer Daniels Midland Co.
o Exhibit 52: Archer Daniels Midland Co. - Overview
o Exhibit 53: Archer Daniels Midland Co. - Business segments
o Exhibit 54: Archer Daniels Midland Co. – Key news
o Exhibit 55: Archer Daniels Midland Co. - Key offerings
o Exhibit 56: Archer Daniels Midland Co. - Segment focus
o 10.6 Arkopharma Laboratories
o Exhibit 57: Arkopharma Laboratories - Overview
o Exhibit 58: Arkopharma Laboratories - Product and service
o Exhibit 59: Arkopharma Laboratories - Key offerings
o 10.7 BASF SE
o Exhibit 60: BASF SE - Overview
o Exhibit 61: BASF SE - Business segments
o Exhibit 62: BASF SE – Key news
o Exhibit 63: BASF SE - Key offerings
o Exhibit 64: BASF SE - Segment focus
o 10.8 Bayer AG
o Exhibit 65: Bayer AG - Overview
o Exhibit 66: Bayer AG - Business segments
o Exhibit 67: Bayer AG – Key news
o Exhibit 68: Bayer AG - Key offerings
o Exhibit 69: Bayer AG - Segment focus
o 10.9 Glanbia Plc
o Exhibit 70: Glanbia Plc - Overview
o Exhibit 71: Glanbia Plc - Business segments
o Exhibit 72: Glanbia Plc - Key offerings
o Exhibit 73: Glanbia Plc - Segment focus
o 10.10 GNC Holdings Inc.
o Exhibit 74: GNC Holdings Inc. - Overview
o Exhibit 75: GNC Holdings Inc. - Business segments
o Exhibit 76: GNC Holdings Inc. - Key offerings
o Exhibit 77: GNC Holdings Inc. - Segment focus
o 10.11 Hi-Tech Pharmaceuticals Inc.
o Exhibit 78: Hi-Tech Pharmaceuticals Inc. - Overview
o Exhibit 79: Hi-Tech Pharmaceuticals Inc. - Product and service
o Exhibit 80: Hi-Tech Pharmaceuticals Inc. - Key offerings
o 10.12 Koninklijke DSM NV
o Exhibit 81: Koninklijke DSM NV - Overview
o Exhibit 82: Koninklijke DSM NV - Business segments
o Exhibit 83: Koninklijke DSM NV – Key news
o Exhibit 84: Koninklijke DSM NV - Key offerings
• 12. Appendix
o 12.1 Scope of the report
o 12.1.1 Market definition
o 12.1.2 Objectives
o 12.1.3 Notes and caveats
o 12.2 Currency conversion rates for US$
o Exhibit 85: Currency conversion rates for US$
o 12.3 Research Methodology
o Exhibit 86: Research Methodology
o Exhibit 87: Validation techniques employed for market sizing
o Exhibit 88: Information sources
o 12.4 List of abbreviations

o
o 1: Key Finding 1
o 2: Key Finding 2
o 3: Key Finding 3
o 4: Key Finding 5
o 5: Key Finding 6
o 6: Key Finding 7
o 7: Key Finding 8
o 8: Parent market
o 9: Market characteristics
o 10: Offerings of vendors included in the market definition
o 11: Market segments
o 12: Global - Market size and forecast 2020 - 2025 ($ million)
o 13: Global market: Year-over-year growth 2020 - 2025 (%)
o 14: Five forces analysis 2020 & 2025
o 15: Bargaining power of buyers
o 16: Bargaining power of suppliers
o 17: Threat of new entrants
o 18: Threat of substitutes
o 19: Threat of rivalry
o 20: Market condition - Five forces 2020
o 21: Distribution channel - Market share 2020-2025 (%)
o 22: Comparison by Distribution channel
o 23: Retail - Market size and forecast 2020-2025 ($ million)
o 24: Retail - Year-over-year growth 2020-2025 (%)
o 25: Online - Market size and forecast 2020-2025 ($ million)
o 26: Online - Year-over-year growth 2020-2025 (%)
o 27: Market opportunity by Distribution channel
o 28: Customer landscape
o 29: Market share By Geographical Landscape 2020-2025 (%)
o 30: Geographic comparison
o 31: North America - Market size and forecast 2020-2025 ($ million)
o 32: North America - Year-over-year growth 2020-2025 (%)
o 33: Europe - Market size and forecast 2020-2025 ($ million)
o 34: Europe - Year-over-year growth 2020-2025 (%)
o 35: Asia - Market size and forecast 2020-2025 ($ million)
o 36: Asia - Year-over-year growth 2020-2025 (%)
o 37: ROW - Market size and forecast 2020-2025 ($ million)
o 38: ROW - Year-over-year growth 2020-2025 (%)
o 39: Key leading countries
o 40: Market opportunity By Geographical Landscape ($ million)
o 41: Impact of drivers and challenges
o 42: Vendor landscape
o 43: Landscape disruption
o 44: Industry risks
o 45: Vendors covered
o 46: Market positioning of vendors
o 47: Abbott Laboratories - Overview
o 48: Abbott Laboratories - Business segments
o 49: Abbott Laboratories - Key offerings
o 50: Abbott Laboratories - Key customers
o 51: Abbott Laboratories - Segment focus
o 52: Amway Corp. - Overview
o 53: Amway Corp. - Product and service
o 54: Amway Corp. - Key offerings
o 55: Amway Corp. - Key customers
o 56: Amway Corp. - Segment focus
o 57: Archer Daniels Midland Co. - Overview
o 58: Archer Daniels Midland Co. - Business segments
o 59: Archer Daniels Midland Co. - Key offerings
o 60: Archer Daniels Midland Co. - Key customers
o 61: Archer Daniels Midland Co. - Segment focus
o 62: Arkopharma Laboratories - Overview
o 63: Arkopharma Laboratories - Product and service
o 64: Arkopharma Laboratories - Key offerings
o 65: Arkopharma Laboratories - Key customers
o 66: Arkopharma Laboratories - Segment focus
o 67: BASF SE - Overview
o 68: BASF SE - Business segments
o 69: BASF SE - Key offerings
o 70: BASF SE - Key customers
o 71: BASF SE - Segment focus
o 72: Bayer AG - Overview
o 73: Bayer AG - Business segments
o 74: Bayer AG - Key offerings
o 75: Bayer AG - Key customers
o 76: Bayer AG - Segment focus
o 77: Glanbia Plc - Overview
o 78: Glanbia Plc - Business segments
o 79: Glanbia Plc - Key offerings
o 80: Glanbia Plc - Key customers
o 81: Glanbia Plc - Segment focus
o 82: GNC Holdings Inc. - Overview
o 83: GNC Holdings Inc. - Business segments
o 84: GNC Holdings Inc. - Key offerings
o 85: GNC Holdings Inc. - Key customers
o 86: GNC Holdings Inc. - Segment focus
o 87: Hi-Tech Pharmaceuticals Inc. - Overview
o 88: Hi-Tech Pharmaceuticals Inc. - Product and service
o 89: Hi-Tech Pharmaceuticals Inc. - Key offerings
o 90: Hi-Tech Pharmaceuticals Inc. - Key customers
o 91: Hi-Tech Pharmaceuticals Inc. - Segment focus
o 92: Koninklijke DSM NV - Overview
o 93: Koninklijke DSM NV - Business segments
o 94: Koninklijke DSM NV - Key offerings
o 95: Koninklijke DSM NV - Key customers
o 96: Koninklijke DSM NV - Segment focus
o 97: Currency conversion rates for US$
o 98: Research Methodology
o 99: Validation techniques employed for market sizing
o 100: Information sources
o 101: List of abbreviations